Mainstream genomics is still nascent but further decline in sequencing costs will drive adoption. Unprecedented intelligence (i.e. big data) involving the genotypic and phenotypic data of individuals will completely reengineer our health system over the next decade.

Genomics is a game changer that will reshape not only the clinical health system but also our personal wellness and lifestyle decisions.